Axeon Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Karnal, Haryana, India, established in 2012.
2012 Karnal, Haryana, India Struck Off
Last Updated:
About Axeon Pharmaceuticals Private Limited

Axeon Pharmaceuticals Private Limited, a struck off private limited company, was established on 04 April 2012 in Karnal, Haryana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232HR2012PTC045585. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Devi Dyal (Director), Dheeraj Kaushal (Director), Ravinder Kumar (Director). Past directors included Devi Dyal. It is based at House No 925 Sector 6, Karnal, Haryana, 132001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232HR2012PTC045585

  • Registration Number

    045585

  • Incorporation Date

    04 April 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 10 Months
Company report

Axeon Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axeon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Axeon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Devi Dyal Director 04 Apr 2012 Current
Dheeraj Kaushal Director 04 Apr 2012 Current
Ravinder Kumar Director 04 Apr 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Apr 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axeon Pharmaceuticals.

Enhance accessibility to Axeon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Axeon Pharmaceuticals revenue growth over time
Axeon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axeon Pharmaceuticals?

Unlock access to Axeon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Axeon Pharmaceuticals?

Unlock and access historical data on people associated with Axeon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axeon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axeon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axeon Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Devi Dyal was appointed as a Director was appointed as a Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was documented.

  • Director Appointment

    Dheeraj Kaushal was appointed as a Director was appointed as a Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ravinder Kumar was appointed as a Director was appointed as a Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was documented.

  • Company Incorporation

    Axeon Pharmaceuticals Private Limited was registered on 04 Apr 2012 with Roc Delhi & aged 13 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axeon Pharmaceuticals Private Limited?

The CIN of Axeon Pharmaceuticals Private Limited is U24232HR2012PTC045585.

Where is Axeon Pharmaceuticals Private Limited headquartered?

Axeon Pharmaceuticals Private Limited is headquartered at House No 925 Sector 6, Karnal, Haryana, 132001.

When was Axeon Pharmaceuticals Private Limited incorporated?

Axeon Pharmaceuticals Private Limited was incorporated on 04 April 2012.

Who are the current directors of Axeon Pharmaceuticals Private Limited?

The current directors of Axeon Pharmaceuticals Private Limited are

What is the primary industry of Axeon Pharmaceuticals Private Limited?

The primary industry of Axeon Pharmaceuticals Private Limited is Chemicals.

Is Axeon Pharmaceuticals Private Limited a listed company?

Axeon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Axeon Pharmaceuticals Private Limited?

The authorized capital of Axeon Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available